195 related articles for article (PubMed ID: 34206468)
1. Convalescent Plasma for Pregnant Women with COVID-19: A Systematic Literature Review.
Franchini M; Prefumo F; Grisolia G; Bergamini V; Glingani C; Pisello M; Presti F; Zaffanello M
Viruses; 2021 Jun; 13(7):. PubMed ID: 34206468
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
[TBL] [Abstract][Full Text] [Related]
4. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Piechotta V; Iannizzi C; Chai KL; Valk SJ; Kimber C; Dorando E; Monsef I; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013600. PubMed ID: 34013969
[TBL] [Abstract][Full Text] [Related]
5. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959
[TBL] [Abstract][Full Text] [Related]
6. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Chai KL; Valk SJ; Piechotta V; Kimber C; Monsef I; Doree C; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 Oct; 10():CD013600. PubMed ID: 33044747
[TBL] [Abstract][Full Text] [Related]
7. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
Trials; 2021 May; 22(1):343. PubMed ID: 34001215
[TBL] [Abstract][Full Text] [Related]
8. Use of convalescent plasma in pregnant women with early stage COVID-19 infection in a tertiary care hospital in Dubai, February to March 2021: a case series study.
Adan H; Harb D; Hazari K; Abdelkareem W; Khan FN; Zouaoui M; Raouf M; Elsawy D; Azar AJ; Khamis AH; Ammar A
BMC Pregnancy Childbirth; 2022 Sep; 22(1):730. PubMed ID: 36155102
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of pregnant women with COVID-19 and their neonates.
Mirbeyk M; Saghazadeh A; Rezaei N
Arch Gynecol Obstet; 2021 Jul; 304(1):5-38. PubMed ID: 33797605
[TBL] [Abstract][Full Text] [Related]
10. The use of convalescent plasma for pediatric patients with SARS-CoV-2: A systematic literature review.
Zaffanello M; Piacentini G; Nosetti L; Franchini M
Transfus Apher Sci; 2021 Apr; 60(2):103043. PubMed ID: 33388249
[TBL] [Abstract][Full Text] [Related]
11. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.
Wooding DJ; Bach H
Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241
[TBL] [Abstract][Full Text] [Related]
12. Current trends and geographical differences in therapeutic profile and outcomes of COVID-19 among pregnant women - a systematic review and meta-analysis.
Dubey P; Thakur B; Reddy S; Martinez CA; Nurunnabi M; Manuel SL; Chheda S; Bracamontes C; Dwivedi AK
BMC Pregnancy Childbirth; 2021 Mar; 21(1):247. PubMed ID: 33761892
[TBL] [Abstract][Full Text] [Related]
13. Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review.
Juan J; Gil MM; Rong Z; Zhang Y; Yang H; Poon LC
Ultrasound Obstet Gynecol; 2020 Jul; 56(1):15-27. PubMed ID: 32430957
[TBL] [Abstract][Full Text] [Related]
14. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of the results of convalescent plasma therapy applied to pregnant women diagnosed as COVID-19- positive in a pandemic center: A prospective cohort study.
Erol SA; Tanaçan A; Apaydın H; Ayhan ŞG; Oluklu D; Hendem DU; Ünlü S; Erden A; Tekin ÖM; Omma A; Ateş İ; Küçükşahin O; Şahin D
Turk J Med Sci; 2022 Jun; 52(3):554-564. PubMed ID: 36326345
[TBL] [Abstract][Full Text] [Related]
16. Convalescent Plasma Treatment in Patients with Covid-19: A Systematic Review and Meta-Analysis.
Jorda A; Kussmann M; Kolenchery N; Siller-Matula JM; Zeitlinger M; Jilma B; Gelbenegger G
Front Immunol; 2022; 13():817829. PubMed ID: 35197981
[TBL] [Abstract][Full Text] [Related]
17. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
[TBL] [Abstract][Full Text] [Related]
18. Convalescent plasma transfusion for the treatment of COVID-19: Systematic review.
Rajendran K; Krishnasamy N; Rangarajan J; Rathinam J; Natarajan M; Ramachandran A
J Med Virol; 2020 Sep; 92(9):1475-1483. PubMed ID: 32356910
[TBL] [Abstract][Full Text] [Related]
19. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ
Trials; 2021 May; 22(1):342. PubMed ID: 34001174
[TBL] [Abstract][Full Text] [Related]
20. The Efficacy of Convalescent Plasma Use in Critically Ill COVID-19 Patients.
Tirnea L; Bratosin F; Vidican I; Cerbu B; Turaiche M; Timircan M; Margan MM; Marincu I
Medicina (Kaunas); 2021 Mar; 57(3):. PubMed ID: 33799535
[No Abstract] [Full Text] [Related]
[Next] [New Search]
